These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 208376)

  • 1. Distribution and regulation of the phosphodiesterases of muscle tissues.
    Gain KR; Appleman MM
    Adv Cyclic Nucleotide Res; 1978; 9():221-31. PubMed ID: 208376
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?
    Strada SJ; Thompson WJ
    Adv Cyclic Nucleotide Res; 1978; 9():265-83. PubMed ID: 208379
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H; Endo T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
    Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
    Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW; Daly JW
    Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.
    Manganiello VC; Yamamoto T; Elks M; Lin MC; Vaughan M
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():291-301. PubMed ID: 6326529
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of acupuncture on the activities of phosphodiesterases in rat brain.
    Zhang TJ; Ma CH; Sun SM; Dong XT; Lu ZS
    J Tradit Chin Med; 1985 Dec; 5(4):285-8. PubMed ID: 3010000
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic nucleotide phosphodiesterase activities of the human liver: comparison between control and Reye's syndrome samples.
    Kang ES
    Pediatr Res; 1978 Jul; 12(7):761-6. PubMed ID: 211480
    [No Abstract]   [Full Text] [Related]  

  • 9. Age related changes in cardiac and aortic phosphodiesterase activities in normotensive and hypertensive rats.
    Lugnier C; Stoclet JC
    Biochem Pharmacol; 1979 Dec; 28(24):3581-7. PubMed ID: 231449
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiplicity within cyclic nucleotide phosphodiesterases.
    Rybalkin SD; Beavo JA
    Biochem Soc Trans; 1996 Nov; 24(4):1005-9. PubMed ID: 8968501
    [No Abstract]   [Full Text] [Related]  

  • 11. Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.
    Worby A; Mensah LM; Murray KJ
    Biochem Soc Trans; 1992 May; 20(2):129S. PubMed ID: 1327896
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M; Harris DN
    Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
    [No Abstract]   [Full Text] [Related]  

  • 13. The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes.
    Perez de Gracia B; Rhoads AR; West WL
    Experientia; 1980 Jul; 36(7):824-5. PubMed ID: 6249634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential susceptibility to biological detergents of the particulate cGMP-stimulated phosphodiesterase from rat heart: preservation of the allosteric properties of the solubilized enzyme.
    Timouyasse L; Prigent AF; Némoz G; Lagarde M; Pachéco H
    Biochem Int; 1989 Aug; 19(2):287-99. PubMed ID: 2554908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotide phosphodiesterase activity in cardiac and vascular smooth muscle of the spontaneously hypertensive rat.
    Taylor JE; Shirachi DY
    Proc West Pharmacol Soc; 1977; 20():307-10. PubMed ID: 197543
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterase activity in the mussel Mytilus edulis L. [proceedings].
    Abreu-Grobois FA; Newton RP; Smith CJ
    Biochem Soc Trans; 1977; 5(5):1348-51. PubMed ID: 200501
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
    Levin RM; Weiss B
    Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of adenylate cyclase inhibitor (ACI) on guanylate cyclase, phosphodiesterase and other enzymes in heart.
    Lehotay DC; Levey GS; Vesely DL; Bornet EP; Ray MV; Entman ML; Schwartz A
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):55-65. PubMed ID: 14979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.